Ivermectin and outcomes from Covid‐19 pneumonia: A systematic review and meta‐analysis of randomized clinical trial studies

Ivermectin is an FDA‐approved drug for a parasitic disease that has broad antiviral activity. This study aims to analyse the efficacy of ivermectin in improving the Covid‐19 outcomes. We systematically searched the PubMed, Europe PMC and ClinicalTrials.gov database using specific keywords related to...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Rev Med Virol
Main Authors: Hariyanto, Timotius Ivan, Halim, Devina Adella, Rosalind, Jane, Gunawan, Catherine, Kurniawan, Andree
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2021
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8209939/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rmv.2265
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker